Bumper Offer - Urjas oil Just @ Rs. 1
StayHappi Clobetasole Propionate Cream is an allopathic medicine The correct dosage of StayHappi Clobetasole Propionate Cream depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
StayHappi Clobetasole Propionate Cream is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when StayHappi Clobetasole Propionate Cream is used -
Moderate
Mild
Is the use of StayHappi Clobetasole Propionate Cream safe for pregnant women?
Pregnant women may experience moderate side effects from StayHappi Clobetasole Propionate Cream. It is best to stop taking StayHappi Clobetasole Propionate Cream immediately and inform your doctor if you notice any discomfort.
Is the use of StayHappi Clobetasole Propionate Cream safe during breastfeeding?
StayHappi Clobetasole Propionate Cream may have very limited harmful effects for breastfeeding women.
What is the effect of StayHappi Clobetasole Propionate Cream on the Kidneys?
StayHappi Clobetasole Propionate Cream is not harmful for kidneys.
What is the effect of StayHappi Clobetasole Propionate Cream on the Liver?
StayHappi Clobetasole Propionate Cream is not harmful for the liver.
What is the effect of StayHappi Clobetasole Propionate Cream on the Heart?
There are no any side effects of StayHappi Clobetasole Propionate Cream for the heart.
StayHappi Clobetasole Propionate Cream should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take StayHappi Clobetasole Propionate Cream unless your doctor advises you to do so -
Is this StayHappi Clobetasole Propionate Cream habit forming or addictive?
Forming a habit of StayHappi Clobetasole Propionate Cream has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
StayHappi Clobetasole Propionate Cream does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
StayHappi Clobetasole Propionate Cream should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of StayHappi Clobetasole Propionate Cream in mental disorders is not effective.
Interaction between Food and StayHappi Clobetasole Propionate Cream
Due to a lack of research, nothing can be said about the consequences of taking StayHappi Clobetasole Propionate Cream together with food.
Interaction between Alcohol and StayHappi Clobetasole Propionate Cream
Information about the interaction of StayHappi Clobetasole Propionate Cream and alcohol is not currently available because this topic has not been researched yet.
Yes, StayHappi Clobetasole Propionate Cream is safe to use, if applied in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as skin atrophy (skin thinning), burning or stinging sensation of the skin. If you experience above-mentioned side after using this drug then inform your doctor and follow his/her instructions.
No, StayHappi Clobetasole Propionate Cream alone should not be used for jock itch also known as tinea cruris because it is a fungal infection and StayHappi Clobetasole Propionate Cream is not an antifungal agent and it is not effective against fungi. Hence StayHappi Clobetasole Propionate Cream should not be used for the treatment of jock itch. For the treatment of jock itch, you can use a combination of StayHappi Clobetasole Propionate Cream and antifungal drugs such as miconazole and fluconazole.
StayHappi Clobetasole Propionate Cream contains clobetasol which is presumed to work by promoting the induction of inhibitory proteins (lipocortins) in the body. Lipocortins prevents the release of arachidonic acid which causes synthesis and release of certain chemicals such as histamine, leukotrienes, and prostaglandins that causes inflammation. In this way StayHappi Clobetasole Propionate Cream prevents the skin inflammation which provides relief to the patient from rash, itching, and redness.
Yes, StayHappi Clobetasole Propionate Cream might be used for the treatment of lichen sclerosus (LS) which is a skin condition that causes thinning of the skin and white patches, generally in the genital area. Clinical studies have found StayHappi Clobetasole Propionate Cream to be effective in the treatment of lichen sclerosus (LS).
Yes, StayHappi Clobetasole Propionate Cream might cause dry skin in few cases only. However, the exact cause behind dry skin is unknown. If you are experiencing excessive dryness of skin after applying this drug then you are advised to use a skin moisturizer. Skin moisturizer should be applied only after 30 minutes of applying this drug so that the StayHappi Clobetasole Propionate Cream can be absorbed by the skin.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
